Innovative Therapy for Alzheimer's Disease
ROSSCA Project
Revolutionizing Alzheimer's Treatment with Nanozymes
About Us
Welcome to ROSSCA, a pioneering European Project dedicated to developing a new strategy against Alzheimer's disease.
Our focus is on creating a synthetic nanozyme that can target and disrupt amyloid-beta and hyperphosphorylated tau deposits, while restoring redox equilibrium through innovative antioxidant enzyme mimetics.
Our Research
Innovating hope: advancing treatment for Alzheimer's disease.
Advancing Alzheimer's Treatment
Objective
Innovative Nanozyme Development
Our primary goal is to design a magnetically triggerable synthetic nanozyme that can effectively target and disrupt amyloid-beta and hyperphosphorylated tau deposits in the brain. By mimicking ROS-scavenging antioxidant enzymes, we aim to restore redox balance and combat Alzheimer's progression.
Approach
Cutting-Edge Technology Implementation
We employ cutting-edge technology to develop a dual-function nanozyme that can selectively target Alzheimer's disease markers. Our approach involves precise magnetically triggerable mechanisms to enhance therapeutic efficacy and reduce side effects, paving the way for a more effective Alzheimer's therapy.
Innovation
Revolutionizing Alzheimer's Treatment
At ROSSCA, we are committed to revolutionizing Alzheimer's treatment through innovative nanozyme technology. Our research focuses on developing a groundbreaking therapy that can address the root causes of the disease, offering new hope for patients and caregivers.